167 related articles for article (PubMed ID: 36517780)
21. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study.
Yang Z; Lu S; Shi M; Yuan H; Wang Z; Ni Z; He C; Zheng Y; Zhu Z; Liu W; Yao X; Zhang J; Li C; Yan M; Yan C; Zhu Z
Gastric Cancer; 2024 Mar; 27(2):387-399. PubMed ID: 38143257
[TBL] [Abstract][Full Text] [Related]
22. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
23. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
[TBL] [Abstract][Full Text] [Related]
24. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
25. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
26. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
[TBL] [Abstract][Full Text] [Related]
27. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
Komatsu S; Shioaki Y; Furuke H; Ohta A; Tsuji R; Tanaka S; Kumano T; Imura KI; Shimomura K; Ikeda J; Taniguchi F; Ueshima Y; Lee CJ; Deguchi E; Ikeda E; Otsuji E
Langenbecks Arch Surg; 2019 Aug; 404(5):599-604. PubMed ID: 31073759
[TBL] [Abstract][Full Text] [Related]
28. Conversion Surgery for Stage IV Gastric Cancer.
Zhang F; Huang X; Song Y; Gao P; Zhou C; Guo Z; Shi J; Wu Z; Wang Z
Front Oncol; 2019; 9():1158. PubMed ID: 31788445
[TBL] [Abstract][Full Text] [Related]
29. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
Ohnuma H; Sato Y; Onoyama N; Hamaguchi K; Hayasaka N; Sato M; Murase K; Takada K; Miyanishi K; Murakami T; Ito T; Nobuoka T; Takemasa I; Kato J
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2385-2396. PubMed ID: 33534051
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology.
Li B; Miao R; Shan F; Li S; Jia Y; Xue K; Li Z; Ying X; Pang F; Zhang Y; Ji J; Li Z
World J Surg Oncol; 2023 Jul; 21(1):204. PubMed ID: 37434202
[TBL] [Abstract][Full Text] [Related]
31. [Conversion therapy of stage IV gastric cancer].
Tanizawa Y; Terashima M; Tokunaga M; Bando E; Kawamura T; Sugisawa N; Miki Y; Makuuchi R; Yamakawa Y; Kinugasa Y; Kanemoto H; Uesaka K; Yasui H
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2469-73. PubMed ID: 23235167
[TBL] [Abstract][Full Text] [Related]
32. International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).
Yoshida K; Yasufuku I; Terashima M; Young Rha S; Moon Bae J; Li G; Katai H; Watanabe M; Seto Y; Hoon Noh S; Kwang Yang H; Ji J; Baba H; Kitagawa Y; Morita S; Nishiyama M; Kodera Y;
Ann Gastroenterol Surg; 2022 Mar; 6(2):227-240. PubMed ID: 35261948
[TBL] [Abstract][Full Text] [Related]
33. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
34. [Conversion Surgery for Stage IV Gastric Cancer].
Konishi T; Kosuga T; Ichikawa D; Komatsu S; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1208-1210. PubMed ID: 29394583
[TBL] [Abstract][Full Text] [Related]
35. Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy.
Zhang Y; Xu X; Hu C; Du Y; Ding G; Chen J; Zhu X; Xu Z; Wei Q
Transl Cancer Res; 2022 Jul; 11(7):2145-2156. PubMed ID: 35966292
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.
Zhang X; Huang H; Yang D; Wang P; Huang X; Hu Z; Zhang Y; Yan R; Zhu Z; Cai Q
Technol Cancer Res Treat; 2021; 20():15330338211036310. PubMed ID: 34328799
[TBL] [Abstract][Full Text] [Related]
37. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
38. Benefits of Surgery After Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients With Peritoneal Metastasis: A Meta-Analysis.
Gong Y; Wang P; Zhu Z; Zhang J; Huang J; Wang T; Chen J; Xu H
J Surg Res; 2020 Jan; 245():234-243. PubMed ID: 31421368
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
40. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
